✦ LIBER ✦

Defining Benefits and Risks for SERMs in Clinical Trials and Clinical Practice

✍ Scribed by SUSAN R. JOHNSON; BARBARA K. DUNN; MARIETTA ANTHONY

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit/Risk Assessment of SERM Therapy

✍ JOSEPH P. COSTANTINO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Weighing the Benefits and Risks in Clini

✍ WORTA McCASKILL-STEVENS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Defining the Pharmacologically Intractab

✍ Stephen D. Silberstein; David W. Dodick; Starr Pearlman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Electronic compliance monitoring in clin

✍ J.Todd Sahlroot; Gordon W. Pledger 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Perspectives on assessing benefits and r

✍ Stephen McConnell; Jason Karlawish; Bruno Vellas; Steven DeKosky 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 78 KB

From Anemia Trials to Clinical Practice:

✍ Daniel W. Coyne 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB